First experience of hemadsorption with HA60 cartridges in newborns and small infants with septic shock: a case series - Takeaways - MDSpire

First experience of hemadsorption with HA60 cartridges in newborns and small infants with septic shock: a case series

  • By

  • Gabriella Bottari

  • Cristina Maccarrone

  • Antonio Torelli

  • Matteo Di Nardo

  • Anna Teresa Mazzeo

  • Corrado Cecchetti

  • Isabella Guzzo

  • June 5, 2026

  • 0 min

Share

  • 1

    The study reports a case series of four pediatric patients, including two neonates, treated with HA60 hemoadsorption for septic shock.

  • 2

    All patients received standard therapy, and three out of four patients survived, indicating potential safety of HA60 hemoadsorption.

  • 3

    No major adverse events were observed during the use of HA60 hemoadsorption in this vulnerable population.

  • 4

    The study emphasizes the need for larger trials to confirm the efficacy and safety of HA60 hemoadsorption in pediatric septic shock.

  • 5

    HA60 cartridges are designed for low-weight patients, featuring reduced priming volumes to minimize risks associated with extracorporeal circulation.

Original Source(s)

First experience of hemadsorption with HA60 cartridges in newborns and small infants with septic shock: a case series

  • by Gabriella Bottari, Cristina Maccarrone, Antonio Torelli, Matteo Di Nardo, Anna Teresa Mazzeo, Corrado Cecchetti, Isabella Guzzo

  • June 5, 2026

Related Content

Editorial: Pediatric gastroenterology and visualizing the digestive tract

Youth Vaping Is "Predictable" by Design

Product engineering, not individual choice, is driving adolescent nicotine dependence, researchers argue.

Case Report: Invasive pulmonary aspergillosis caused by Aspergillus lentulus in a boy with chronic granulomatous disease